Merck & Co.

6 Global Trends Critical to Patients During the COVID-19 Pandemic

Expert panel of patient advocacy leaders on COVID-19, its impact on patients and moving forward
Blog

The ongoing COVID-19 pandemic has created unprecedented challenges around the world. It has significantly impacted health systems and health care. Merck recently hosted an expert panel of patient advocacy leaders from around the world to discuss shifts in health care and the impact on patients during the next phases of the pandemic. Special Report: COVID-19 and the Patient Perspective summarizes the panel conversation.

Building Sustainable Value for Our Business and Society

Press Release

KENILWORTH, N.J., September 22, 2021 /3BL Media/ - Merck (NYSE: MRK), known as MSD outside the United States and Canada, affirmed its commitment to Environmental, Social, and Governance (ESG) priorities as core to our company and a strong driver of sustainable value for our business and society. In our 2020/2021 ESG Progress Report, we describe our most recent advances toward achieving our ESG priority objectives, as well as our efforts to address the health and economic challenges that the COVID-19 pandemic uncovered and intensified.

Merck Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index

Blog

Merck has received a top score of 100 on the Human Rights Campaign Foundation’s 2021 Corporate Equality Index, the nation’s foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ workplace equality.

Merck Joins Groundbreaking Gender and Diversity KPI Alliance

New alliance supports growing push for corporate diversity
Blog

Merck has joined the groundbreaking Gender and Diversity KPI Alliance (GDKA) to support the adoption and use of a set of Key Performance Indicators (KPIs) to measure gender and diversity in their companies and organizations.

Merck Supports The Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN)

Blog
At Merck, we aspire to improve the health and wellness of people worldwide, and to expand access to our medicines and vaccines. As part of our ongoing commitment to fighting neglected tropical diseases, Merck has announced a $500,000 grant to the World Health Organization’s Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN).
 

In Pursuit of Universal Health Care: Time to Take Public-Private Partnership to the Next Level

By Dr. Naveen Rao
Article
The buzz around public-private partnership (PPP) keeps getting louder. And yes – PPPs are everywhere, operating in virtually every industry sector around the world, including health.
 

Merck & Co., Inc., Kenilworth, N.J., USA Publishes 2016/2017 Corporate Responsibility Report

Article

Merck & Co., Inc., Kenilworth, N.J., USA recently issued its 2016/2017 Global Corporate Responsibility Report. The report provides an overview of the company’s corporate responsibility activities, progress and performance in the areas of Access to Health, Employees, Environmental Sustainability and Ethics & Transparency.

Merck & Co., Inc., Kenilworth, N.J., USA Publishes 2015/2016 Corporate Responsibility Report

Article

Merck & Co., Inc., Kenilworth, N.J., USA recently issued its 2015/2016 Global Corporate Responsibility Report. The report provides an overview of the company’s corporate responsibility activities, progress and performance in the areas of Access to Health, Environmental Sustainability, Employees and Ethics & Transparency.

Highlights from the 2015/2016 report include:

Achieving Triple Impact: Purposeful Engagement that Goes Beyond Checkbook Philanthropy for Shared Value

New workshop helps companies adopt global pro bono, innovation in corporate investment Berlin, Germany
Press Release

SEPTEMBER 22, 2014, Washington, D.C., Berlin, Germany /3BL Media/  On September 25, SAPPYXERA Global, and, UPJ host Achieving Triple Impact, the first workshop of its kind to bring together European corporations in Berlin, Germany to explore how investment in global pro bono programs can achieve triple impact for companies, their employees, and communities worldwide

PYXERA Global Announces Annual 5th International Corporate Volunteerism Conference

Multinational corporations address global pro bono and emerging market growth on April 8th
Press Release

WASHINGTON, March 13, 2014 /3BL Media/ – PYXERA Global proudly announces the event line-up for the Annual International Corporate Volunteerism (ICV) Conference on April 8th, 2014 in Washington, D.C.

Subscribe to Merck & Co.